Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics

Canadian Journal of Anesthesia

Volumn 52, Issue 2, 2005, Pages 176-180

  Hofer, Roger E ^a   Sprung, Juraj ^a   Sarr, Michael G ^b   Wedel, Denise J ^a  

^a DEPARTMENT OF UROLOGY   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DEXMEDETOMIDINE; HEPARIN; IBUPROFEN; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; IPRATROPIUM BROMIDE; NARCOTIC AGENT; OPIATE; OXYCODONE; RANITIDINE; SALBUTAMOL; TRAZODONE; ZOLPIDEM;

ADULT; ANALGESIC ACTIVITY; ANESTHESIA; ARTICLE; BARIATRIC SURGERY; CASE REPORT; CONTINUOUS INFUSION; DRUG USE; EXTUBATION; HUMAN; INTRAOPERATIVE PERIOD; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MORBID OBESITY; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATION DEPRESSION; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; STOMACH BYPASS;

EID: 16344369006     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03027725     Document Type: Article

References (24)

1. Sugerman HJ. Pulmonary function in morbid obesity. Gastroenterol Clin North Am 1987; 16: 25-37.
2. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90: 699-705.
3. Bradley C. Dexmedetomidine - a novel sedative for postoperative sedation. Intensive Crit Care Nurs 2000; 16: 328-9.
4. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4: 302-8.
5. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obesity 2001; 25: 669-75.
6. Paalzow L. Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 1974; 26: 361-3.
7. Maxwell GM. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres®) upon the systemic and coronary haemodynamics and metabolism of intact dogs. Arch Int Pharmacodyn Ther 1969; 181: 7-14.
8. Mizobe T. Adrenergic receptor and alpha 2 agonist - 4: applied and clinical pharmacology of alpha 2 agonist (Japanese). Masui 1997; 46: 1066-70.
9. 2 -adrenergic agonists. Anesthesiology 2000; 93: 1345-9.
10. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-42.
11. Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care 2001; 7: 221-6.
12. Bloor BC, Abdul-Rasool I, Temp J, Jenkins S, Valcke C, Ward DS. The effects of medetomidine, an α2-adrenergic agonist, on ventilatory drive in the dog. Acta Vet Scand Suppl 1989; 85: 65-70.
13. Jarvis DA, Duncan SR, Segal IS, Maze M. Ventilatory effects of clonidine alone and in the presence of alfentanil, in human volunteers. Anesthesiology 1992; 76: 899-905.
14. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: 1125-33.
15. Erice F, Fox GS, Salib YM, Romano E, Meakins JL, Magder SA Diaphragmatic function before and after laparoscopic cholecystectomy. Anesthesiology 1993; 79: 966-75; discussion 27A-8A.
16. Sharma RR, Axelsson H, Oberg A, et al. Diaphragmatic activity after laparoscopic cholecystectomy. Anesthesiology 1999; 91: 406-13.
17. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-8; discussion 269-70.
18. Aho MS, Erkola OA, Scheinin H, Lehtinen AM, Korttila KT Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 1991; 73: 112-8.
19. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg 1992; 75: 940-6.
20. 2 adrenergic receptor. Anesthesiology 1988; 69: 818-23.
21. 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988; 67: 611-5.
22. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136-42.
23. Triltsch AE, Welte M, von Homeyer P, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002; 30: 1007-14.
24. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for post-operative analgesia after major inpatient surgery. Anesth Analg 2004; 98: 153-8.